Où? London (UK)
Quand? 30.01.2019 au 31.01.2019
CAR-T cell therapy has shown unparalleled success in haematological malignancies, paving the way for the field of immuno-oncology. Introducing…the third European CAR-T Congress in London on 30 – 31 January 2019.
In 2017 two therapies achieved FDA approval in the USA, and following recent approval by the EMA, it is a landmark time for the industry. Despite huge successes, there are still a number of hurdles to overcome before CAR-T can be effective in mainstream oncology beyond haematological malignancies.
Join 80+ to address the opportunities and challenges that presently face the CAR-T field and maximise the potential of this ground-breaking therapy
